NCT06745427Not yet recruiting
A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia
Source: ClinicalTrials.gov · Last updated 20 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
We will investigate the safety and efficiency of fertility-sapring treatment in ypung women witg endometrial cancer and endometrial intraepithelial hyperplasia
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 17 Dec 2024
- Start date
- 15 Jan 2025
- Primary completion date
- 15 Jan 2028
- Lead sponsor
- Region Stockholm
- Diseases
- Endometrial cancer
- NCT number
- NCT06745427
What you commit to
- Study type: Observational
- Planned participants: 100
- From 15 Jan 2025 to the primary completion date, 15 Jan 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Not English och Swedish speaking
Who the study is looking for
- Fertility sparing treatment of EC and EIN.
- 18-45 Years old
- From start study (Jan 2025 - end study Jan 2028)
- All centras in Sweden
Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.